Today at a glance: in today's bearish session, the Canadian cannabis producer shed around 3.29% in quick fashion, found support around the 58.1 cents level and finally closed at 59.72 cents. In contrast, the day's events followed Friday's session in which the stock closed at 61.75 cents.
The MACD index is indicating that momentum is shifting from bullish to bearish following a negative crossover. When the MACD falls below the signal line, it is typically considered to be a bearish development favoring short positions. Despite this, Aurora Cannabis could begin to recover as it approaches significant support, now 2 cents away from 57.6733 cents. Dipping below could be an indication that further losses are ahead. Aurora Cannabis's lower Bollinger Band® is at 59.6148 cents, indicating that the asset has overextended to the downside and could, therefore, bounce back as buyers look for bargains.
In general, examining the technical analysis landscape, although indicators are mixed further drawbacks may be next for Aurora Cannabis.
Aurora Cannabis was not the only decliner in the health care sector; Abbott Laboratories goes down 1.13% today to close at $111.66. Novo Nordisk slumps 1.26% today to close at $172.65.
On the other hand, positive performances could be seen by looking at other health care stocks as Medtronic traded at $89.69 after closing today's trading day at $85.73 (up 4.62%).
With markets struggling for positive sentiment, upcoming macro data could potentially attract buyers in the market as tomorrow at 14:00 UTC data for United States Consumer Confidence will be released, with an expected decline to 104 from the preceding figure of 104.2.
Furthermore, United States Building Permits will be released tomorrow at 13:30 UTC. United States New Home Sales (Mar) scheduled to come out tomorrow at 14:00 UTC.
Pointing downwards for around 2 months.